Difference between revisions of "Vimentin"

From Libre Pathology
Jump to navigation Jump to search
Line 6: Line 6:
*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal  | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref>
*[[Malignant melanoma]].<ref name=pmid27052289>{{Cite journal  | last1 = Mısır | first1 = AF. | last2 = Durmuşlar | first2 = MC. | last3 = Zerener | first3 = T. | last4 = Gün | first4 = BD. | title = Primary malignant melanoma. | journal = Saudi Med J | volume = 37 | issue = 4 | pages = 446-9 | month = Apr | year = 2016 | doi = 10.15537/smj.2016.4.15017 | PMID = 27052289 }}</ref>


===Vimentin and cytokeratin positivity===
Common tumours:
*[[Renal cell carcinoma]].<ref name=pmid18318577/>
*[[Endometrial carcinoma]].<ref name=pmid12647218/>
*[[Ovarian serous carcinoma]].<ref name=pmid18318577>{{Cite journal  | last1 = Bahrami | first1 = A. | last2 = Truong | first2 = LD. | last3 = Ro | first3 = JY. | title = Undifferentiated tumor: true identity by immunohistochemistry. | journal = Arch Pathol Lab Med | volume = 132 | issue = 3 | pages = 326-48 | month = Mar | year = 2008 | doi = 10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2 | PMID = 18318577 }}</ref>
*[[Papillary thyroid carcinoma]].<ref name=pmid18318577/>
*[[Sarcomatoid carcinoma]] (spindle cell carcinoma).<ref name=pmid18318577/>
Rare tumours:
*[[Synovial sarcoma]].<ref name=pmid15338724>{{cite journal |author=Llombart-Bosch A, Lopez-Guerrero JA, Peydro-Olaya A |title=Synovial sarcoma (SS): new perspectives supported by modern technology |journal=Arkh. Patol. |volume=64 |issue=3 |pages=39–47 |year=2002 |pmid=15338724 |doi= |url=}}</ref>
*[[Rhabdoid tumour]].<ref name=pmid11557780>{{cite journal |author=Itakura E, Tamiya S, Morita K, ''et al.'' |title=Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence |journal=Mod. Pathol. |volume=14 |issue=9 |pages=854–61 |year=2001 |month=September |pmid=11557780 |doi=10.1038/modpathol.3880401 |url=http://www.nature.com/modpathol/journal/v14/n9/full/3880401a.html}}</ref>
*[[Epithelioid sarcoma]].<ref name=pmid10452506>{{cite journal |author=Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF |title=Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis |journal=Hum. Pathol. |volume=30 |issue=8 |pages=934–42 |year=1999 |month=August |pmid=10452506 |doi= |url=}}</ref>
*[[Epithelioid angiosarcoma]].<ref name=pmid18318577/>
*[[Desmoplastic small round cell tumour]].<ref name=pmid18318577/>
*[[Anaplastic thyroid carcinoma]].<ref name=pmid18318577/>
*Biphasic [[malignant mesothelioma]].<ref name=pmid18318577/>
*[[Carcinosarcoma]].<ref name=pmid18318577/>
Common tumours that uncommonly have the pattern:
*[[Gastric adenocarcinoma]].<ref>URL: [http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165 http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165]. Accessed on: 26 April 2011.</ref>
==Negative==
==Negative==
*Most [[carcinoma]]s.
*Most [[carcinoma]]s.

Revision as of 23:19, 1 August 2016

Vimentin staining in a poorly differentiated carcinoma.

Vimentin is a common immunostain. It marks most soft tissue lesions and malignant melanoma. It is usually negative in carcinoma.

Positive

Vimentin and cytokeratin positivity

Common tumours:

Rare tumours:

Common tumours that uncommonly have the pattern:

Negative

See also

References

  1. ↑ Mısır, AF.; Durmuşlar, MC.; Zerener, T.; Gün, BD. (Apr 2016). "Primary malignant melanoma.". Saudi Med J 37 (4): 446-9. doi:10.15537/smj.2016.4.15017. PMID 27052289.
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 Bahrami, A.; Truong, LD.; Ro, JY. (Mar 2008). "Undifferentiated tumor: true identity by immunohistochemistry.". Arch Pathol Lab Med 132 (3): 326-48. doi:10.1043/1543-2165(2008)132[326:UTTIBI]2.0.CO;2. PMID 18318577.
  3. ↑ Cite error: Invalid <ref> tag; no text was provided for refs named pmid12647218
  4. ↑ Llombart-Bosch A, Lopez-Guerrero JA, Peydro-Olaya A (2002). "Synovial sarcoma (SS): new perspectives supported by modern technology". Arkh. Patol. 64 (3): 39–47. PMID 15338724.
  5. ↑ Itakura E, Tamiya S, Morita K, et al. (September 2001). "Subcellular distribution of cytokeratin and vimentin in malignant rhabdoid tumor: three-dimensional imaging with confocal laser scanning microscopy and double immunofluorescence". Mod. Pathol. 14 (9): 854–61. doi:10.1038/modpathol.3880401. PMID 11557780. http://www.nature.com/modpathol/journal/v14/n9/full/3880401a.html.
  6. ↑ Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF (August 1999). "Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis". Hum. Pathol. 30 (8): 934–42. PMID 10452506.
  7. ↑ URL: http://cat.inist.fr/?aModele=afficheN&cpsidt=2504165. Accessed on: 26 April 2011.
Retrieved from "https://librepathology.org/w/index.php?title=Vimentin&oldid=45620"